Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Sorafenib

Sorafenib: A Comprehensive Overview

Sorafenib is an oral multikinase inhibitor used to treat various types of cancer, including renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and radioactive iodine-resistant advanced thyroid carcinoma. It works by inhibiting the activity of several kinases, enzymes that play a crucial role in the growth and spread of cancer cells.

Uses

Sorafenib is used to treat:

- Renal cell carcinoma (RCC): a type of kidney cancer

- Hepatocellular carcinoma (HCC): a type of liver cancer

- Radioactive iodine-resistant advanced thyroid carcinoma: a type of thyroid cancer

How Sorafenib Works

Sorafenib works by inhibiting the activity of several kinases, including:

- Vascular endothelial growth factor receptors (VEGFR): involved in the formation of new blood vessels that feed the growth of cancer cells

- Platelet-derived growth factor receptors (PDGFR): involved in the growth and survival of cancer cells

- Raf kinases: involved in the signaling pathways that promote cell growth and survival

Dosage and Administration

Sorafenib is available in tablet form, typically taken twice a day. The dosage depends on the individual's condition, age, and weight.

- RCC and HCC: 400 mg twice a day

- Thyroid carcinoma: 400 mg twice a day

Side Effects

Common side effects of sorafenib include:

- Diarrhea

- Fatigue

- Nausea and vomiting

- Skin rash

- Hypertension

Precautions and Contraindications

Before taking sorafenib, consult your doctor if you have:

- Pregnancy or breastfeeding: sorafenib may harm the fetus or baby

- Bleeding disorders: sorafenib may increase the risk of bleeding

- Cardiovascular disease: sorafenib may increase the risk of cardiovascular events

- Kidney or liver disease: sorafenib may affect kidney or liver function

Interactions

Sorafenib may interact with:

- Warfarin: increasing the risk of bleeding

- Cyclosporine: increasing the risk of kidney damage

- Ketoconazole: increasing the levels of sorafenib in the blood

Pharmacology

Sorafenib is a multikinase inhibitor with a molecular weight of approximately 464 Da. It is metabolized in the liver and excreted in the feces.

Brand Names and Availability

Sorafenib is marketed under the brand name Nexavar. It is available in many countries, including the United States, Europe, and Asia.

Conclusion

Sorafenib is an effective treatment option for various types of cancer, including RCC, HCC, and thyroid carcinoma. While generally well-tolerated, it's essential to be aware of the potential side effects and interactions associated with this medication. By consulting with a healthcare provider and following the recommended dosage, individuals can effectively manage their symptoms and improve their quality of life.

Additional Resources

For more information on sorafenib, including user reviews and ratings, please consult reputable online sources, such as the National Institutes of Health (NIH) or the World Health Organization (WHO).

References

1. National Institutes of Health (NIH). (2022). Sorafenib.

2. World Health Organization (WHO). (2022). Sorafenib.

3. MedlinePlus. (2022). Sorafenib.